Also, one of the distinguished features of our study is the high serum level of pre-therapeutic PSA (median 50 ng/ml) and all cases were primary cases; however, in literature, most of the primary diagnosed cases are either organ-confined or locally advanced cancer and those with high serum PSA level are mostly recurrent cancer after failure of the primary therapy. The gene discussed is KLK3; the disease is cancer.